search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


The effects of structured follow-up from primary care for patients during their cancer journey. A randomized controlled trial.


- candidate number24518
- NTR NumberNTR5909
- ISRCTNISRCTN no longer applicable
- Date ISRCTN created
- date ISRCTN requested
- Date Registered NTR21-jun-2016
- Secondary IDs15-075/C  METC
- Public TitleThe effects of structured follow-up from primary care for patients during their cancer journey. A randomized controlled trial.
- Scientific TitleThe effects of structured follow-up from primary care for patients during their cancer journey. A randomized controlled trial.
- ACRONYMGRIP study
- hypothesisStructured follow-up from primary care will effect patients‘ satisfaction with care and health care utilisation.
- Healt Condition(s) or Problem(s) studiedCancer
- Inclusion criteria1) Newly diagnosed with the following types of cancer: breast cancer, colorectal cancer, gynaecologic cancer, lung cancer or melanoma.
2) Cancer therapy is to be initiated with curative intent.
3) Patients’ general practitioner participates in the GRIP study. 4) Patient is 18 years old or older. 5) Inclusion within two weeks after diagnosis.
- Exclusion criteria1) Major psychiatric disease and personality disorders.
2) Unable to fill in questionnaires.
- mec approval receivedyes
- multicenter trialyes
- randomisedyes
- masking/blindingNone
- controlActive
- groupParallel
- Type2 or more arms, randomized
- Studytypeintervention
- planned startdate 1-mrt-2015
- planned closingdate31-dec-2017
- Target number of participants150
- Interventions1) Time out consultation with general practitioner
2) Home visits by Homecare Oncology Nurse
- Primary outcome1) Patient satisfaction with care
2) Health care utilisation
- Secondary outcome1) Health related quality of life
2) Employment
3) Effect on patient empowerment
4) Shared decision making
5) Mental health
- Timepoints1) Time Out consultation with the GP after diagnosis and before final treatment decision.
2) Contact with HON during and after treatment, at least 3 contacts.
3) Questionnaires will be send at the moment of consensus for participation (T0), two weeks after inclusion (T1), three months after inclusion (T2), six months after inclusion (T3), nine months after inclusion (T4) and twelve months after inclusion (T5).
Timing of T3-T5 depends on duration of therapy. T5 will always be send 3 months after end of therapy.
- Trial web site
- statusopen: patient inclusion
- CONTACT FOR PUBLIC QUERIESMD, PhD, MSc C.W. Helsper
- CONTACT for SCIENTIFIC QUERIESMD, PhD, MSc C.W. Helsper
- Sponsor/Initiator University Medical Center Utrecht (UMCU)
- Funding
(Source(s) of Monetary or Material Support)
Danone Ecosystem Fund
- Publications
- Brief summaryHealth care professionals and patients advocate transfer of care and follow-up from secondary to primary care in the Netherlands, due to the increase in the number of chronic cancer patients, cancer incidence and improving outcomes of cancer therapy and expanding possibilities for personalized cancer care. However, the effectiveness of structured patient follow-up form primary care during the cancer journey has not been studied yet. Therefore, the GRIP study, a multicenter randomized controlled two-arm trial, evaluates the effects of structured follow-up care form diagnosis, for cancer patients provided from primary care on healthcare utilization and patient satisfaction with care.
Country of recruitment: The Netherlands
- Main changes (audit trail)
- RECORD21-jun-2016 - 23-aug-2016


  • Indien u gegevens wilt toevoegen of veranderen, kunt u een mail sturen naar nederlands@trialregister.nl